HQL vs. IYH
Compare and contrast key facts about Tekla Life Sciences Investors (HQL) and iShares U.S. Healthcare ETF (IYH).
IYH is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Health Care Index. It was launched on Jun 12, 2000.
Performance
HQL vs. IYH - Performance Comparison
Loading graphics...
HQL vs. IYH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 0.18% | 45.48% | 11.03% | 4.23% | -19.21% | 5.52% | 23.72% | 25.53% | -16.18% | 25.41% |
IYH iShares U.S. Healthcare ETF | -5.02% | 13.16% | 2.99% | 2.14% | -4.46% | 23.41% | 15.56% | 20.80% | 5.80% | 22.27% |
Returns By Period
In the year-to-date period, HQL achieves a 0.18% return, which is significantly higher than IYH's -5.02% return. Over the past 10 years, HQL has underperformed IYH with an annualized return of 8.95%, while IYH has yielded a comparatively higher 9.42% annualized return.
HQL
- 1D
- 2.26%
- 1M
- -2.28%
- YTD
- 0.18%
- 6M
- 11.70%
- 1Y
- 45.72%
- 3Y*
- 18.90%
- 5Y*
- 6.76%
- 10Y*
- 8.95%
IYH
- 1D
- 2.14%
- 1M
- -7.49%
- YTD
- -5.02%
- 6M
- 5.70%
- 1Y
- 2.58%
- 3Y*
- 5.41%
- 5Y*
- 5.36%
- 10Y*
- 9.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HQL vs. IYH — Risk / Return Rank
HQL
IYH
HQL vs. IYH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and iShares U.S. Healthcare ETF (IYH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HQL | IYH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.88 | 0.14 | +1.74 |
Sortino ratioReturn per unit of downside risk | 2.52 | 0.33 | +2.19 |
Omega ratioGain probability vs. loss probability | 1.32 | 1.04 | +0.28 |
Calmar ratioReturn relative to maximum drawdown | 3.04 | 0.30 | +2.73 |
Martin ratioReturn relative to average drawdown | 11.18 | 0.62 | +10.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| HQL | IYH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.88 | 0.14 | +1.74 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 0.36 | -0.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.57 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.43 | -0.12 |
Correlation
The correlation between HQL and IYH is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
HQL vs. IYH - Dividend Comparison
HQL's dividend yield for the trailing twelve months is around 11.74%, more than IYH's 1.31% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 11.74% | 10.85% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% |
IYH iShares U.S. Healthcare ETF | 1.31% | 1.19% | 1.25% | 1.18% | 1.10% | 0.94% | 1.16% | 1.14% | 1.95% | 1.10% | 1.29% | 2.02% |
Drawdowns
HQL vs. IYH - Drawdown Comparison
The maximum HQL drawdown since its inception was -62.65%, which is greater than IYH's maximum drawdown of -43.12%. Use the drawdown chart below to compare losses from any high point for HQL and IYH.
Loading graphics...
Drawdown Indicators
| HQL | IYH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.65% | -43.12% | -19.53% |
Max Drawdown (1Y)Largest decline over 1 year | -11.91% | -10.52% | -1.39% |
Max Drawdown (5Y)Largest decline over 5 years | -38.86% | -17.91% | -20.95% |
Max Drawdown (10Y)Largest decline over 10 years | -38.86% | -28.40% | -10.46% |
Current DrawdownCurrent decline from peak | -4.87% | -8.17% | +3.30% |
Average DrawdownAverage peak-to-trough decline | -22.37% | -8.97% | -13.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.90% | 5.58% | -1.68% |
Volatility
HQL vs. IYH - Volatility Comparison
Tekla Life Sciences Investors (HQL) has a higher volatility of 7.98% compared to iShares U.S. Healthcare ETF (IYH) at 4.87%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than IYH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| HQL | IYH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.98% | 4.87% | +3.11% |
Volatility (6M)Calculated over the trailing 6-month period | 16.20% | 10.57% | +5.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.48% | 17.96% | +6.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.56% | 14.79% | +5.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.41% | 16.70% | +5.71% |